Eam Global Investors LLC Aldeyra Therapeutics, Inc. Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $1.11 Million - $1.59 Million	-140,198 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$10.44 - $14.85 $1.46 Million - $2.08 Million	140,198 New	140,198 $1.59 Million
Q1 2019 May 10, 2019	SELL	$7.14 - $9.85 $913,291 - $1.26 Million	-127,912 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.26 - $13.29 $299,823 - $548,850	41,298 Added 47.68%	127,912 $1.06 Million
Q3 2018 Nov 08, 2018	BUY	$6.8 - $14.35 $588,975 - $1.24 Million	86,614 New	86,614 $1.2 Million

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $291M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.